FOR IMMEDIATE RELEASE
July 31, 2006
Boston, M.A. — Leading clinicians, medical organizations, and the 2006 Cardiometabolic Health Congress will convene to discuss and debate state-of-the-art therapies to prevent type 2 diabetes and reduce cardiovascular risk in the growing number of patients at increased cardiometabolic risk. The congress will take place October 19-21, 2006 at the Marriott Copley Place in Boston, M.A. and will attract practicing endocrinology, cardiology and primary care clinicians throughout North America.
“In previous centuries, the major scourges were from acute infectious diseases, today, the impact is from the compilation of chronic diseases, including diabetes, obesity, and cardiovascular disease,” according to Jay Skyler, MD, Professor of Medicine, Pediatrics, and Psychology at the University of Miami Miller School of Medicine. “The biggest health problem facing the world today is from the combined impact of obesity, diabetes, and cardiovascular disease.”
An unprecedented group of prestigious medical organizations have joined together in support of the 2006 Cardiometabolic Health Congress – making the congress the most comprehensive and influential educational forum available to the medical community. These supporters include the American Diabetes Association; the American Heart Association (Councils on Clinical Cardiology, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism); The Endocrine Society; American Society of Hypertension; American Society of Preventive Cardiology; Preventive Cardiology Nursing Association; American College of Preventive Medicine; Association of Black Cardiologists; Association of Physician Assistants in Cardiology; American Society of Endocrine Physician Assistants; American Medical Woman's Association; and the Society of Atherosclerosis Imaging and Prevention.
“The current trends in obesity pose the greatest challenge to our healthcare system over the next decades,” said Christie Ballantyne, MD, Professor of Medicine at Baylor College of Medicine. “It is vital that physicians and health care providers understand how to identify and manage patients with obesity that are at increased risk for the development of diabetes and cardiovascular disease.”
“The 2006 Cardiometabolic Health Congress will be one of the first educational events to fully evaluate cardiometabolic health from a definition of cardiac risk to the widest variety of treatment modalities,” said Richard Nesto, MD, Associate Professor, Harvard Medical School. “Field experts will come together and help to fully define cardiometabolic risk within the context of patient care both in the here and now.”
“The 2006 Cardiometabolic Health Congress is an extremely important initiative,” stated Paolo Raggi, MD, Professor of Medicine and Radiology at Emory University School of Medicine. “Cardiometabolic risk is an epidemic which Americans have long overlooked and underestimated as far as inherent cardiovascular risk is concerned.”
About the 2006 Cardiometabolic Health Congress
The 2006 Cardiometabolic Health Congress will translate the latest clinical data and research into practical and effective approaches to identify and manage the approximately 25% of the US population at increased Cardiometabolic risk. The goal of the congress is to improve patient outcomes through early identification and intervention strategies for patients with, or at risk of developing, diabetes and cardiovascular disease.
Please visit www.cardiometabolichealth.com for additional details including meeting schedule, faculty, and association support. For more information and media interviews, please contact Liz Coscia at 732-758-0276 or via email at [email protected].